OPKO Health, Inc. (OPK)
NGS · Common · CUSIP 68375N103
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for OPK and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
68375N103 (prev. 301610101 )
Market Cap
Large Cap · $6 Billion
Previous Name
Exegenics
Business: OPKO Health, Inc. is a multi-national pharmaceutical and diagnostics company that aims to establish industry-leading positions in large and rapidly growing medical markets by leveraging their discovery, development, and commercialization expertise and their novel and proprietary technologies. They intend to leverage their global commercialization expertise to pursue acquisitions of commercial businesses that will both drive their growth and provide geographically diverse sales and distribution opportunities.

Company Contact

CEO
Phillip Frost, M.D.
CFO
Adam Logal
Headquarters
4400 Biscayne Blvd., Miami, FL 33137
Phone
305-575-4100
Investor Relations
305-575-4100 · contact@opko.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »